Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Astra (AstraZeneca) presents new agents for GI inflammatory disorders

July 5, 1999

Howard Hughes researchers uncover mechanism of interferon resistance in HCV

July 5, 1999

Naturally occurring anti-H. pylori substances discovered by Takeda

July 2, 1999

Relief in sight for female patients with IBS: Glaxo Wellcome files NDA for alosetron

July 1, 1999

Shiseido describes new gastric antisecretory agents for ulcers

June 30, 1999

Enzon and Schering-Plough revise agreement for PEG-Intron

June 30, 1999

Antiinflammatory mechanism(s) of orazipone undergoes study at Orion

June 29, 1999

Immunex renews gene license with Digital Gene Technologies

June 25, 1999

Amarillo Biosciences reaches IFN-alpha development agreement in China

June 24, 1999

Rebetol combination therapy for treatment of chronic HCV launched in Germany

June 22, 1999

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...